HRMY
Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. (HRMY) has 3 SEC Form 4 filings (5 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: May 18, 2026.
Insiders have net sold $139K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Jeffrey Dayno
- Employees:293
- HQ:Plymouth Meeting, PA, US
- IPO:2020-08-19
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$139K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$2.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Kapadia SandipFirst filing | CHIEF FINANCIAL OFFICER | Sale | 3,746 | $139K | Jan 28 | SEC ↗ |
Related companies
Harmony Biosciences Holdings, Inc. is in the Healthcare sector.